Advertisement
Screener

Minerva Neurosciences, Inc. (NERV) Basic Shares Outstanding (Weighted Average)

Minerva Neurosciences, Inc. Basic Shares Outstanding (Weighted Average)

Minerva Neurosciences, Inc. (NERV) reported Basic Shares Outstanding (Weighted Average) of 46.60 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07

  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 46.60M shares, a 515.66% increase year-over-year.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 43.90M shares, a 480.00% increase year-over-year.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 11.15M shares, a 47.28% increase year-over-year.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 7.57M shares, a 0.00% change year-over-year.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 8.46M shares, a 11.82% increase from fiscal 2024.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 7.57M shares, a 16.33% increase from fiscal 2023.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 6.51M shares, a 21.84% increase from fiscal 2022.
  • Minerva Neurosciences, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 5.34M shares, a 0.00% decline from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 3 month as first filedWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 9 month as first filedWeighted Average Number of Shares Outstanding, Basic 12 monthWeighted Average Number of Shares Outstanding, Basic 12 month as first filed
2026-06-3046.60M shares
10-Q · filed 2026-08-07
45.26M shares
10-Q · filed 2026-08-07
33.88M shares
derived: average of 3 quarters · filed 2026-08-07
27.30M shares
derived: average of 4 quarters · filed 2026-08-07
2026-03-3143.90M shares
10-Q · filed 2026-05-05
27.52M shares
derived: average of 2 quarters · filed 2026-05-05
20.87M shares
derived: average of 3 quarters · filed 2026-05-05
17.55M shares
derived: average of 4 quarters · filed 2026-08-07
2025-12-3111.15M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11
9.36M shares
derived: average of 2 quarters · filed 2026-03-11
8.76M shares
derived: average of 3 quarters · filed 2026-08-07
8.46M shares
10-K · filed 2026-03-11
2025-09-307.57M shares
10-Q · filed 2025-11-05
7.57M shares
derived: average of 2 quarters · filed 2026-08-07
7.57M shares
10-Q · filed 2025-11-05
7.57M shares
derived: average of 4 quarters · filed 2026-08-07
2025-06-307.57M shares
10-Q · filed 2026-08-07
7.57M shares
10-Q · filed 2026-08-07
7.57M shares
derived: average of 3 quarters · filed 2026-08-07
7.57M shares
derived: average of 4 quarters · filed 2026-08-07
2025-03-317.57M shares
10-Q · filed 2026-05-05
7.57M shares
derived: average of 2 quarters · filed 2026-05-05
7.57M shares
derived: average of 3 quarters · filed 2026-05-05
7.57M shares
derived: average of 4 quarters · filed 2026-05-05
2024-12-317.57M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11
7.57M shares
derived: average of 2 quarters · filed 2026-03-11
7.57M shares
derived: average of 3 quarters · filed 2026-03-11
7.57M shares
10-K · filed 2026-03-11
2024-09-307.57M shares
10-Q · filed 2025-11-05
7.57M shares
derived: average of 2 quarters · filed 2025-11-05
7.57M shares
10-Q · filed 2025-11-05
7.57M shares
derived: average of 4 quarters · filed 2025-11-05
2024-06-307.57M shares
10-Q · filed 2025-08-14
7.57M shares
10-Q · filed 2025-08-14
7.57M shares
derived: average of 3 quarters · filed 2025-08-14
7.57M shares
derived: average of 4 quarters · filed 2025-08-14
2024-03-317.57M shares
10-Q · filed 2025-05-13
7.57M shares
derived: average of 2 quarters · filed 2025-05-13
7.57M shares
derived: average of 3 quarters · filed 2025-05-13
7.06M shares
derived: average of 4 quarters · filed 2025-05-13
2023-12-317.58M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
7.57M shares
derived: average of 2 quarters · filed 2025-02-25
6.89M shares
derived: average of 3 quarters · filed 2025-02-25
6.51M shares
10-K · filed 2025-02-25
2023-09-307.57M shares
10-Q · filed 2024-11-05
6.54M shares
derived: average of 2 quarters · filed 2024-11-05
6.15M shares
10-Q · filed 2024-11-05
5.94M shares
derived: average of 4 quarters · filed 2024-11-05
2023-06-305.51M shares
10-Q · filed 2024-08-06
5.43M shares
10-Q · filed 2024-08-06
5.40M shares
derived: average of 3 quarters · filed 2024-08-06
5.38M shares
derived: average of 4 quarters · filed 2024-08-06
2023-03-315.34M shares
10-Q · filed 2024-05-01
5.34M shares
derived: average of 2 quarters · filed 2024-05-01
5.34M shares
derived: average of 3 quarters · filed 2024-05-01
5.34M shares
derived: average of 4 quarters · filed 2024-05-01
2022-12-315.34M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
5.34M shares
derived: average of 2 quarters · filed 2024-02-22
5.34M shares
derived: average of 3 quarters · filed 2024-02-22
5.34M shares
10-K · filed 2024-02-22
2022-09-305.34M shares
10-Q · filed 2023-11-07
5.34M shares
derived: average of 2 quarters · filed 2023-11-07
5.34M shares
10-Q · filed 2023-11-07
5.34M shares
derived: average of 4 quarters · filed 2023-11-07
2022-06-305.34M shares
10-Q · filed 2023-08-01
5.34M shares
10-Q · filed 2023-08-01
5.34M shares
derived: average of 3 quarters · filed 2023-08-01
5.34M shares
derived: average of 4 quarters · filed 2023-08-01
2022-03-315.34M shares
10-Q · filed 2023-05-15
5.34M shares
derived: average of 2 quarters · filed 2023-05-15
5.34M shares
derived: average of 3 quarters · filed 2023-05-15
14.69M shares
derived: average of 4 quarters · filed 2023-05-15
2021-12-315.34M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08
5.34M shares
derived: average of 2 quarters · filed 2023-03-08
17.80M shares
derived: average of 3 quarters · filed 2023-03-08
5.34M shares
10-K · filed 2023-03-08
42.72M shares
10-K · filed 2022-03-01
2021-09-305.34M shares
10-Q · filed 2022-11-09
42.72M shares
10-Q · filed 2021-11-08
24.03M shares
derived: average of 2 quarters · filed 2022-11-09
5.34M shares
10-Q · filed 2022-11-09
42.72M shares
10-Q · filed 2021-11-08
2021-06-3042.72M shares
10-Q · filed 2021-08-02
42.72M shares
10-Q · filed 2021-08-02
2020-12-3142.70M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
42.31M shares
derived: average of 2 quarters · filed 2022-03-01
41.37M shares
derived: average of 3 quarters · filed 2022-03-01
40.82M shares
10-K · filed 2022-03-01
2020-09-3041.92M shares
10-Q · filed 2021-11-08
40.70M shares
derived: average of 2 quarters · filed 2021-11-08
40.20M shares
10-Q · filed 2021-11-08
2020-06-3039.48M shares
10-Q · filed 2021-08-02
39.33M shares
10-Q · filed 2021-08-02
2019-12-3139.04M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08
39.03M shares
derived: average of 2 quarters · filed 2021-03-08
39.03M shares
derived: average of 3 quarters · filed 2021-03-08
39.01M shares
10-K · filed 2021-03-08
2019-09-3039.03M shares
10-Q · filed 2020-11-02
39.03M shares
derived: average of 2 quarters · filed 2020-11-02
39.01M shares
10-Q · filed 2020-11-02
2019-06-3039.03M shares
10-Q · filed 2020-08-03
39.00M shares
10-Q · filed 2020-08-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
ADC Therapeutics SA (ADCT)$0.163B-1.39
LIFECORE BIOMEDICAL, INC. DE (LFCR)United States$0.163B-8.50
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
Annexon, Inc. (ANNX)United States$0.147B-4.22
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
PepGen Inc. (PEPG)United States$0.186B-1.73
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
Fortress Biotech, Inc. (FBIO)United States$0.188B0.91